Clopidogrel Outperforms Aspirin for Secondary Prevention in Coronary Artery Disease

An individual‑patient meta‑analysis presented at the ESC Congress and published in The Lancet found a 14% lower rate of major cardiovascular or cerebrovascular events without more major bleeding.